$BALL

Glew Mandy sold $359K of BALL

Glew Mandy (SVP and President, EMEA) sold 5,626 shares of BALL Corp (BALL) at $63.80 ($0.36M total) on 2026-08-25.

Original reporting
SEC EDGAR · Glew Mandy
Published Aug 26, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 26, 2026, 9:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BALL
Neutral
high confidence
Mentioned
$BALL
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BALLNeutralLow
01

Why it matters

Minor dilution of insider ownership; unlikely to move price materially.

02

Market read

Small insider sale; limited trading relevance.

03

Timing

filed today

Relevance 4/10Novelty 5/10Timing: filed today

Background

SEC Form 4 filing discloses insider transaction.

Company-level read

Ticker impact

$BALLNeutralHigh confidence
Context

Insider SVP sold 5,626 shares for $359K, reducing holdings to 7,209 shares.

Expected impact

Minimal impact, price likely unchanged.

Evidence & confidence

Sale size is small relative to market cap and typical daily volume.

Key entities

  • Glew Mandy

    SVP and President, EMEA of Ball Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BALLMed

Ball Stock Outlook: Is Wall Street Bullish or Bearish?

Ball Corp (BALL) reported Q2 FY2026 earnings Aug. 4. Net sales rose 19.7% YoY to $4.0B, driven by higher volumes and price/mix tied to aluminum prices. Comparable EPS increased 14.4% to $1.03. For FY2026, Ball expects >10% comparable diluted EPS growth and free cash flow >$900M. Analysts’ consensus is Moderate Buy; Citi raised its target to $75.

$BALLMed

Ball (BALL) Q2 2026 Earnings Call Transcript

Ball (BALL) reported Q2 2026 results in an earnings call transcript. It said global volumes rose 4.3% year over year, comparable operating earnings increased 7.7%, and comparable diluted EPS grew 14.4%. For 2026, it reiterated 10%+ comparable diluted EPS growth, free cash flow above $900 million, and plans to return about $800 million to shareholders.

$BALLMed

Ball locks in major tropical acquisition

Ball Horticultural said it will expand its tropical category by acquiring Aris Horticulture’s Tradewinds Hibiscus genetics and parts of its tropical commercial business. Ball FloraPlant will take ownership of the full Tradewinds portfolio effective Aug. 3, while Ball Seed will handle commercial liner and prefinished/finished programs. Aris continues production and accepts orders through Aug. 17.

$BALLMedAI 8/10

Ball Releases Q2 2026 Financial Results

Ball Corporation reported Q2 2026 results that beat expectations, with comparable EPS of $1.03 versus $1.00 consensus, up 3.0%. Net income was $276.0M and revenue rose to $4.00B, up 19.7% year over year. Aluminum packaging shipments increased 4.3%, and beverage packaging in North and Central America generated $2.01B revenue.